Drug intelligence / Profile preview

Jian Gu Sheng pill

Development stage: Unknown
Lead developer: Zhejiang Hisun Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Jian Gu Sheng pill is a Traditional Chinese Medicine (TCM) formulation currently undergoing clinical investigation for the treatment of osteonecrosis of the femoral head. It is being evaluated in a multicenter, randomized, double-blind, controlled trial, often administered in conjunction with Tongluo Sheng Gu Capsule. The specific active ingredients and detailed mechanism of action are not fully elucidated in the provided context, but it is developed within the framework of traditional Chinese medicine for bone-related conditions.

Other names: Jian Gu Sheng健骨生丸

Beyond the preview

Go deeper on Jian Gu Sheng pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jian Gu Sheng pill.

Explore the full profile